The median number of BCG doses per patient was 9 in the combination arm and 16 in the monotherapy arm. Phase 3 trial results suggest that adjuvant treatment with mitomycin and bacillus Calmette ...

The median radiographic progression-free survival was not reached in the niraparib arm and was 29.5 months in the placebo arm. Adding niraparib to abiraterone acetate plus prednisone (AAP) and ...

Investigators presented an interim analysis of the phase 3 ENLIGHTED trial of photodynamic therapy in patients with low-grade upper-tract urothelial cancer.

Patients with prostate cancer may have a lower risk of recurrence if they take multivitamin supplements after diagnosis, new data suggest.

Source: Getty Images Recent studies assessed artificial intelligence (AI) assistance tools in their ability to provide quality medical recommendations for patients. Artificial intelligence (AI) is ...

Health care data breaches that compromised protected health information more than doubled from 2010 to 2024 in the US, data suggest.

One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent ...

PARP inhibitors demonstrate synergy with radiation, so investigators tested the efficacy and safety of olaparib plus radium-223 in patients with mCRPC and bone metastases in a phase 2 trial.

Adding zilebesiran to a thiazide diuretic or calcium channel blocker may lead to further blood pressure reduction in patients with uncontrolled hypertension. Zilebesiran added to hypertension ...

A prospective study of sex hormone use in patients seeking transgender treatments suggests how these hormones may influence kidney health.